Renal Artery Stenosis Treatment Demand Driven by Rising Prevalence of Atherosclerosis, Says Fact.MR
Fact.MR, a global research & consulting firm, in their updated edition of the report, indicated that the renal artery stenosis treatment market is projected to foresee a moderate growth in 2021 and beyond. Increasing prevalence of coronary artery disease, chronic kidney disease, stroke and peripheral vascular disease is projected to contribute major revenue share in the renal artery stenosis treatment industry.
“Rise in diagnosis rates owing to screening programs, favourable medicare policies, increasing healthcare expenditures are other factors for the expansion of the renal artery stenosis treatment industry. ” states Fact.MR.
Rising Pervasiveness of Atherosclerosis to Propel Growth
The rising pervasiveness of atherosclerosis is projected to be a key factor fueling the expansion of the industry in the forthcoming years. The global pervasiveness of 0.5% atherosclerotic across the globe, and amid 5-4% patients with chronic kidney ailment. Rising peripheral atrial ailment as well as cholesterol problems are expected to increase the requirement for treatment drugs for renal artery stenosis.
Furthermore, lack of exercise, irregular eating timings, unhealthy eating habits, and inactive lifestyles are prompting the demand. Surging hypertension problems amid the general population as well as rising geriatric populace are other aspects influencing the industry growth.
Request a report sample to gain comprehensive market insights at - https://www.factmr.com/connectus/sample?flag=S&rep_id=1489
How Retail Pharmacies are Supporting Market Growth?
Presently, retail pharmacies are anticipated to contribute a higher industry share. The demand for the treatment of renal artery stenosis in the retail pharmacies is surging steadily since it is the most available distribution channel as well as most of the patients are suggested for outpatient treatment.
On the other hand, online pharmacies are gaining momentum, on account of increasing proliferation of virtual market spaces.
How the High Incidence Rates in The US is Affecting Growth?
The US is likely to be the key beneficiary in the industry, on the back of the high frequency of atherosclerosis amid the geriatric population.
The UK and Germany will have the second-biggest share in the industry over the assessment period, due to higher awareness in relation to health-related concerns as well as growing healthcare screening programs.
China, India and South Korea is likely to expand at a notable growth pace CAGR, owing to rising healthcare expenditure and healthcare amenities.
Get Customization on this Report for Specific Country
https://www.factmr.com/connectus/sample?flag=RC&rep_id=1489
Product Approval and Launches Remain Key Focal Areas: Fact.MR Survey
The renal artery stenosis treatment market appears to be fragmented. Fact.MR’s survey indicated that the leading companies are focusing on product launches and approvals to fortify its position. The updated edition of the report offers comprehensive coverage of the projected remain key strategies of the market players. A few of the key companies profiled in the report are Pfizer Inc., Abbott Laborites, Novartis AG, AstraZeneca plc., Merck & Company, Inc., Johnson and Johnson, Sanofi SA, Eli Lilly and Company, Bayer AG, Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc.The latest edition also provides a thorough analysis of the COVID-19 impact on this market.
Explore Fact.MR’s Healthcare Reports
Renal Drugs Market: Delve into Fact.MR’s extensive study on the renal drugs market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.
Nephrogenic Systemic Fibrosis (NSF) Treatment Market: The global nephrogenic systemic fibrosis (NSF) treatment market study published by fact.mr incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.
Narcotic Analgesics Market: Fact.MR’s global narcotic analgesics market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR